Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,858 | 65,508 | 94,952 | 89,324 | 98,182 |
| Marketable Securities | N/A | 17,604 | 36,002 | 2,357 | N/A |
| Receivables | 14,404 | 7,593 | 8,376 | 8,689 | 156 |
| Inventories | 857 | 678 | 171 | 203 | N/A |
| Other current assets | 0 | 13,089 | 37,948 | 0 | 0 |
| TOTAL | $156,252 | $111,207 | $183,181 | $109,634 | $99,937 |
| Non-Current Assets | |||||
| PPE Net | 12,433 | 12,019 | 7,116 | 7,376 | 309 |
| Investments And Advances | 11,148 | 0 | 1,390 | 1,414 | 2,485 |
| Intangibles | 7,377 | 1,417 | 883 | 36,053 | 1,250 |
| Other Non-Current Assets | 39,212 | 16,350 | 53,380 | 16,254 | 14,629 |
| TOTAL | $70,170 | $29,786 | $62,769 | $61,097 | $18,673 |
| Total Assets | $226,422 | $140,993 | $245,950 | $170,731 | $118,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36,585 | 35,396 | 28,618 | 24,460 | 10,465 |
| Accrued Expenses | N/A | 149 | N/A | 11,940 | N/A |
| Other current liabilities | 27 | 991 | 29,592 | 18,134 | 114 |
| TOTAL | $45,616 | $55,614 | $71,438 | $56,565 | $10,579 |
| Non-Current Liabilities | |||||
| Long Term Debt | 82,426 | 60,425 | 39,212 | 22,528 | 23,174 |
| Other Non-Current Liabilities | 87,548 | 63,000 | 47,758 | 24,865 | 6,039 |
| TOTAL | $108,274 | $65,636 | $54,010 | $31,198 | $23,758 |
| Total Liabilities | $153,890 | $121,250 | $125,448 | $87,763 | $34,337 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,233 | 4,089 | 3,425 | 3,356 | 3,236 |
| Common Shares | 574 | 717 | 551 | 49 | 47 |
| Retained earnings | -436,234 | -396,274 | -312,127 | -245,251 | -190,156 |
| Other shareholders' equity | 46,317 | 17,891 | 67,929 | 44,473 | 27,427 |
| TOTAL | $72,532 | $19,743 | $120,502 | $82,968 | $84,273 |
| Total Liabilities And Equity | $226,422 | $140,993 | $245,950 | $170,731 | $118,610 |